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and low anterior neck ( 50 Gy /25 #). The highest grade of 
mucositis assessed according to RTOG criteria and the time to 
development of that grade (in weeks since initiation) where 
noted in the data. The baseline characteristics of the 
patients utilized for the study are displayed in the table 
attached. All the statistical analysis was done using SPSS 
version 16.0.( table attached). 
Results: Of the analysed 122 patients , 44.4 % vs 59.3 % 
developed RTOG Grade 3 or4 mucositis after morning vs 
evening RT, respectively (p = 0.10) and the median time to 
development of severe mucositis was prolonged in the 
morning group (6 weeks vs 5 weeks). Morning RT was also 
associated with significantly lesser no of patients for whom 
treatment had to be interrupted due to severe mucositis 17.5 
% vs 40.7 % (p = 0.005). 58.2% of the patients who smoked (n 
=55) during RT , developed Grade 3 or 4 mucositis compared 
to 46.3 % who didn't smoke .(p = 0.396) Concurrent 
chemotherapy was associated with 65.2 % Grade 3 or 4 
mucositis compared to 35.7 % of patients who didn't receive 
concurrent chemotherapy. ( p= 0.001 ) 
Conclusions: Our analysis has shown a decrease in the 
development of severe mucositis when RT is delivered in the 
morning hours when compared to evening , though not 
statistically significant .The patients able to complete the RT 
course, without any interruptions , due to severe reactions 
were significantly higher in the morning session compared to 
evening . Advanced head and neck malignancies are still a 
difficult proposition to treat and hence limiting normal tissue 
toxicity is critical . The circadian rhythm of the cell cycle 
progression and its radiobiological potential need to be 
studied in detail. 
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Purpose/Objective: Several feature of zebrafish are making 
them amenable for investigation on therapeutic approaches 
such as ionizing radiation. The establishment of zebrafish 
model for comprehensive radiobiological research stands in 
the focus of our investigation, comparing the radiation effect 
curves of neutron and photon irradiation. Our final aim is to 
develop an appropriate vertebrate model in order to 
investigate the relative biological effectiveness of laser 
driven ionizing radiation. 
Materials and Methods: After careful dosimetry series of 
viable zebrafish embryos were exposed to a single fraction 
whole-body neutron-irradiation (1,25; 1,875; 2; 2,5 Gy) at 
the research reactor of the Technical University of Budapest 
and to conventional 6 MeV photon beam at 24 hour post-
fertilization (hpf). The survival and morphologic 
abnormalities (pericardial edema, spine curvature) of each 
embryo were assessed for each experiment at 24-hour 
intervals from the point of fertilization up to 168 hpf 
(defining the dose lethal for 50% (LD50)).  
Results: In the zebrafish embryo model LD50 at 20 Gy dose 
level was defined and the same lethality were found at 2 Gy 
dose from the reactor neutron beam resulting RBE of 10. 
Dose-dependent organ perturbations were detected on 
macroscopic (shortening of the body length, spine curvature, 
microcephaly, micro-ophthalmia, micrognathia, pericardial 
edema, and inhibition of yolk sac resorption) and microscopic 
(marked cellular changes in skin, cardiac, gastrointestinal 
system) with the same magnitude of dose difference. 
Conclusions: In our observations we found that zebrafish 
embryo model can be used for investigating the effects of 
different type of ionizing radiation and this system proved to 
be highly efficient vertebrate model for preclinical 
examinations. 
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Purpose/Objective: It has been reported that blood 
endothelial microparticles (EMP) contribute to blood 
coagulation activation, angiogenesis and inflammation as well 
are marker of endothelial cells (ECs) activation and/or 
apoptosis in various clinical settings. During radiotherapy 
(RT) or radiochemotherapy (RCT) of head and neck cancer 
(HNC) patients acute radiation reaction appears which is 
associated with ECs activation. However, information on EMP 
in HNC patients during RT/RCT is lacking. The aim of the 
study was to assess if EMP are a marker of ECs activation and 
damage as a result of ionizing radiation during the process of 
RT/RCT of HNC patients. 
Materials and Methods: Blood samples obtained from HNC 
patients undergoing radical RT/RCT (before, 1 day and 3 
months after its cessation) and from healthy control subjects 
were prospectively examined. Endothelial microparticles 
were measured by flow cytometry. The monoclonal 
antibodies purchased from Becton Dickinson, USA were used 
in the study: CD31 stained FITC, CD62E stained APC, PE-Cy5 
labeled anti-human CD42b, PE labeled anti-human CD142 and 
kappa isotype control: FITC labeled mouse IgG1, APC labeled 
